微芯生物:向特定对象发行股票注册申请获中国证监会同意批复

Group 1 - The core point of the article is that Microchip Biotech has received approval from the China Securities Regulatory Commission (CSRC) for its stock issuance to specific investors [1] - The approval is valid for 12 months from the date of registration consent [1] - The company is required to complete the relevant procedures for the stock issuance within the specified timeframe and fulfill its information disclosure obligations promptly [1]

Chipscreen-微芯生物:向特定对象发行股票注册申请获中国证监会同意批复 - Reportify